UBITAS Biotech
PrivateCompany Overview
UBITAS Biotech is a biotechnology company that develops next-generation protein degradation technology for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
targeted protein degradationTPDproteolysis targeting chimeraPROTAConcology drug discoveryundruggable targetsbiotech platformdrug development partnershipprotein degradercancer therapeuticssmall molecule drugdrug discovery licensingmolecular glue
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UBITAS Biotech Comparables
Compare UBITAS Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PROTIER Biotech Inc. | 85% | |
| Pin Therapeutics | 79% | |
| Orum Therapeutics | 75% | |
UBITAS Biotech Funding Rounds
Historical fundraising activity
UBITAS Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about UBITAS Biotech's valuation, stock price, and market status.
See something wrong or outdated?